Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
LV-305 by Merck for Synovial Sarcoma: Likelihood of Approval
LV-305 is under clinical development by Merck and currently in Phase I for Synovial Sarcoma. According to GlobalData, Phase I...
Data Insights
LV-305 by Merck for Myxoid Liposarcoma: Likelihood of Approval
LV-305 is under clinical development by Merck and currently in Phase I for Myxoid Liposarcoma. According to GlobalData, Phase I...